SOPHiA GENETICS (SOPH) Cost of Revenue (2020 - 2025)

SOPHiA GENETICS's Cost of Revenue history runs 6 years deep, the most recent figure standing at $7.0 million for Q4 2025.

• In Q4 2025, Cost of Revenue rose 24.58% year-over-year to $7.0 million; the TTM figure through Dec 2025 stood at $25.2 million (up 18.64% YoY), while the FY2025 annual figure was $25.2 million, up 18.64% from the prior year.
• Cost of Revenue came in at $7.0 million for Q4 2025 at SOPHiA GENETICS, up from $6.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $7.0 million in Q4 2025 to a low of $3.4 million in Q1 2021.
• A 5-year average of $4.9 million and a median of $5.0 million in 2023 frame the typical range for Cost of Revenue.
• On a YoY basis, Cost of Revenue climbed as much as 131406.38% in 2021 and fell as far as 99.8% in 2021.
• SOPHiA GENETICS's Cost of Revenue stood at $4.1 million in 2021, then slipped by 8.62% to $3.8 million in 2022, then jumped by 37.22% to $5.1 million in 2023, then increased by 9.34% to $5.6 million in 2024, then rose by 24.58% to $7.0 million in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $7.0 million, $6.6 million, and $6.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison